TriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO offering a range of mRNA and nucleic acid–based therapeutic solutions. Headquartered in California, TriLink offers fully integrated mRNA, oligonucleotide, and plasmid manufacturing capacity to support therapeutic, vaccine, and diagnostic customers. The company specializes in mRNA therapeutic development and manufacturing, providing discovery-grade (research use only) mRNA synthesis, high-quality pDNA templates for mRNA products, and GMP mRNA manufacturing for late-phase production. TriLink also provides comprehensive analytical testing and QC assays for characterizing and analyzing mRNA.